In 2012, comparative proteomic profiling with the use of mass spectrometry of highly fractionated plasma from patients with cirrhosis and HCC identified osteopontin (OPN) as a new promising biomarker for the early diagnosis of HCC [110]. The gene discussed is SPP1; the disease is hepatocellular carcinoma.